Donor heart preservation with the potassium channel opener pinacidil: Comparison with University of Wisconsin and St. Thomas' solution

Journal of Heart and Lung Transplantation

Volumn 19, Issue 3, 2000, Pages 286-297

  Hoenicke, Eric M ^a   Peterseim, David S ^a   Ducko, Christopher T ^a   Sun, Xiwu ^a   Damiano, Ralph J ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPLEGIC AGENT; PINACIDIL; PLEGISOL; POTASSIUM CHANNEL STIMULATING AGENT; ST THOMAS HOSPITAL SOLUTION; UNIVERSITY OF WISCONSIN SOLUTION;

CORONARY ARTERY BLOOD FLOW; DONOR; DRUG EFFICACY; HEART FUNCTION; HEART PRESERVATION; HEART PROTECTION; HEART TRANSPLANTATION; HEMODYNAMICS; ISOLATED HEART; PRIORITY JOURNAL; RABBIT; REVIEW;

ADENOSINE; ALLOPURINOL; ANIMALS; BICARBONATES; CALCIUM CHLORIDE; COLD; CORONARY CIRCULATION; GLUTATHIONE; HEART TRANSPLANTATION; INSULIN; MAGNESIUM; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PINACIDIL; POTASSIUM CHANNELS; POTASSIUM CHLORIDE; RABBITS; RAFFINOSE; SODIUM CHLORIDE; VENTRICULAR FUNCTION, LEFT;

EID: 0033994934     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(99)00138-2     Document Type: Article

References (55)

1. Darracott-Cankovic S., Stovin P.G., Wheeldon D., Wallwork J., Wells F., English T.A. Effect of donor heart damage on survival after transplantation. Eur J Cardiothorac Surg. 3:1989;525-532.
2. Duquesnoy R.J., Cramer D.V. Immunologic mechanisms of cardiac rejection. Cardiovasc Clin. 20:1990;87-103.
3. Hearse D.J., Stewart D.A., Braimbridge M.V. Hypothermic arrest and potassium arrest, metabolic and myocardial protection during elective cardiac arrest. Circ Res. 36:1975;481-489.
4. Billingham M.E., Baumgartner W.A., Watson D.C., et al. Distant procurement for human transplantation. Circulation. 62:(suppl):1980;I-11-I-19.
5. Jamieson N.V., Sundberg R., Lindell S., et al. Preservation of the canine liver for 24-48 hours using simple cold storage with UW solution. Transplantation. 46:1988;517-522.
6. Collins G.M., Bravo-Shugarman M., Terasaki P.I. Kidney preservation for transportation initial perfusion and 30 hours' ice storage. Lancet. 2:1969;1219-1222.
7. Galinanes M., Murashita T., Hearse D.J. Long-term hypothermic storage of the mammalian heart for transplantation a comparison using three cardioplegic solutions. J Heart Lung Transplant. 11:1992;624-635.
8. Kawai A., Morita S., Kormos R.L., et al. A clinical trial comparing University of Wisconsin Solution and cold cardioplegic solution with load-independent mechanical parameters. J Heart Lung Transplant. 13:1994;150-156.
9. Menasche P., Pradier F., Grousset C., et al. Improved recovery of heart transplants with a specific kit of preservation solutions. J Thorac Cardiovasc Surg. 105:1993;353-363.
10. Attwell D., Cohen I., Eisner D., Ohba M., Ojeda C. The steady state TTX-sensitive ('window') sodium current in cardiac Purkinje fibres. Pflugers Arch. 379:1979;137-142.
11. Fabiato A. Simulated calcium current can both cause calcium loading in and trigger the calcium release from the sarcoplasmic reticulum of a skinned cardiac cell. J Gen Physiol. 85:1985;291-320.
12. Damiano R.J. The electrophysiology of ischemia and cardioplegia implications for myocardial protection. J Card Surg. 10:(suppl):1995;101-109.
13. Bolli R. Mechanism of myocardial stunning. Circulation. 82:1990;723-728.
14. Gettes L.S., Cascia W.E. Effect of acute ischemia on cardiac electrophysiology In Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. 1992;2021-2054 Raven, New York.
15. Foglia R.P., Steed D.L., Follette D.M., Deland E., Buckberg G.D. Iatrogenic myocardial edema with potassium cardioplegia. J Thorac Cardiovasc Surg. 78:1979;217-222.
16. + channels in cardiac muscle. Nature. 305:1983;147-148.
17. Nichols C.G., Lederer W.J. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol. 261:1991;H1675-H1686.
18. Gross G.J., Auchampach J.A. Role of ATP dependent potassium channels in myocardial ischaemia. Cardiovasc Res. 26:1992;1011-1016.
19. Lawton J.S., Harrington G.C., Allen C.T., Hsia P.-W., Damiano R.J. Jr. Myocardial protection with pinacidil cardioplegia in the blood-perfused heart. Ann Thorac Surg. 61:1996;1680-1688.
20. Lawton J.S., Sepic J.D., Allen C.T., Hsia P.-W., Damiano R.J. Jr. Myocardial protection with potassium-channel openers is as effective as St. Thomas' solution in the rabbit heart. Ann Thorac Surg. 62:1996;31-39.
21. Jayawant M., Stephenson E.R. Jr, Damiano R.J. Jr. Advantages of continuous hyperpolarized arrest with pinacidil over St. Thomas' Hospital solution during prolonged ischemia. J Thorac Cardiovasc Surg. 116:1998;131-138.
22. Ducko CT, Stephenson ER, Jayawant AM, Vigilance DW, Damiano RJ. Potassium channel openers: are they effective as preconditioning agents or additives to St. Thomas' solution? Ann Thorac Surg (Publication pending).
23. Maskal S.L., Fields C.E., Cohen N.M., Damiano R.J. Jr. Persistent electrical activity during hyperpolarized cardiac arrest does not affect postischemic myocardial recovery. Surg Forum. 46:1995;222-224.
24. Stark P.A. Introduction to numerical methods. 1970;196-198 Macmillan, New York.
25. Stringham J.C., Love R.B., Welter D., Canver C.C., Mentzer R.M. Jr. Impact of University of Wisconsin solution on clinical heart transplantation. A comparison with Stanford solution for extended preservation. Circulation. 98:(19 suppl):1998;II157-II161.
26. Drinkwater D.C., Rudis E., Laks H., et al. University of Wisconsin solution versus Stanford cardioplegic solution and the development of cardiac allograft vasculopathy. J Heart Lung Transplant. 14:1995;891-896.
27. Cartier R., Dagenais F., Hollmann C., Carrier M., Pelletier L.C. The role of preservation solutions in coronary endothelial damage during cold storage. Transplantation. 56:1993;997-1000.
28. Cohen N.M., Allen C.A., Hsia P.-W., Nixon T.E., Wise R.M., Damiano R.J. Jr. Electrophysiologic consequences of hyperkalemic cardioplegia during surgical ischemia. Ann Thorac Surg. 57:1994;1076-1083.
29. Damiano R.J. Jr, Cohen N.M. Hyperpolarized arrest attenuates myocardial stunning following global surgical ischemia an alternative to traditional hyperkalemic cardioplegia. J Card Surg. 9:(suppl):1994;517-525.
30. Snabaitis A.K., Shattock M.J., Chamber D.J. Comparison of polarized and depolarized arrest in the isolated rat heart for long-term preservation. Circulation. 96:1997;3148-3156.
31. Sunamori M., Amano J., Miyamoto H., Shirai T., Suzuki A. Relative advantages of nondepolarizing solution to depolarizing University of Wisconsin solution in donor heart preservation. Transplant Proc. 25:1993;1613-1617.
32. Sun X., Ducko C.T., Hoenicke E.M., Zhang X.-Q., Cheung J.Y., Damiano R.J. Jr. Potassium channel openers avoid cardioplegia-induced intracellular calcium accumulation but do not prevent myocardial stunning. Circulation. 100:(suppl I):1999;I-388.
33. Lopez J.R., Jahangir R., Jahangir A., Shen W.K., Terzic A. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells possible implications in cardioplegia. J Thorac Cardiovasc Surg. 112:1996;820-831.
34. Termignon J.L., Pradier F., Petit A., Journois D., Weiss M., Mazmanian M. Effects of calcium concentration, lactobionate content, and sodium/potassium ratio of preservation solutions on resting left ventricular pressure and postreperfusion function of rabbit heterotopic heart transplants. J Heart Lung Transplant. 14:1995;1126-1135.
35. Fremes S.E., Zhang J., Furukawa R.D., Mickle D.A., Wesel R.D. Adenosine pretreatment for prolonged cardiac stage. J Thorac Cardiovasc Surg. 110:1995;293-301.
36. Kirsch M., Baufetron C., Fernandez C., et al. Preconditioning with cromakalim improves long-term myocardial preservation for heart transplantation. Ann Thorac Surg. 66:1998;417-424.
37. Du Z.Y., Hicks M., Spratt P., Mundy J.A., MacDonald P.S. Cardioprotective effects of pinacidil pretreatment and lazaroid (U74500A) preservation in isolated rat hearts after 12-hour hypothermic storage. Transplantation. 66:1998;158-163.
38. Gu K., Kin S., Saitoh Y., et al. Cardioprotective effect of nicorandil in histidine-tryptophan-ketoglutarate solution during the cold storage of isolated hearts. Transplantation. 61:1996;1572-1575.
39. Gregg D.E. Effect of coronary perfusion pressure or coronary flow on oxygen usage of the myocardium. Circulation. 6:1963;497-500.
40. Lawton J.S., Hsia P.-W., McClain L.C., Maier G.W., Damiano R.J. Jr. Myocardial oxygen consumption in the rabbit heart after ischemia hyperpolarized arrest with pinacidil versus depolarized hyperkalemic arrest. Circulation. 96:(Suppl 9):1997;II247-II252.
41. Dijkman M.A., Heslinga J.W., Sipkema P., Westerhof N. Perfusion-induced changes in cardiac contractility depend on capillary perfusion. Am J Physiol. 274:1998;H405-H410.
42. Dijkman M.A., Heslinga J.W., Sipkema P., Westerhof N. Perfusion-induced changes in cardiac contractility and oxygen consumption are not endothelium-dependent. Cardiovasc Res. 33:1997;593-600.
43. Nilsson F.N., Miller V.M., Vanhoutte P.M., McGregor C.G. Methods of cardiac preservation alter the function of the endothelium in porcine coronary arteries. J Thorac Cardiovasc Surg. 102:1991;923-929.
44. Shintani H., Glantz S.A. Effect of disrupting the mitral apparatus on left ventricular function in dogs. Circulation. 87:1993;2001-2015.
45. Grover G.J., Sleph P.G., Dzwonczyk S. Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs. J Cardiovasc Pharmacol. 16:1990;853-864.
46. Jayawant A.M., Stephenson E.R. Jr, Matte G.S., et al. Hyperpolarized arrest with pinacidil is superior to traditional St. Thomas' solution in the intact animal. Surg Forum. 49:1998;192-194.
47. Jayawant A.M., Stephenson E.R. Jr, Baumgarten C.M., Damiano R.J. Jr. Prevention of cell swelling with low chloride St. Thomas' Hospital solution improves postischemic myocardial recovery. J Thorac Cardiovasc Surg. 115:1998;1196-1202.
48. Hoenicke E.M., Sun X., Ducko C.T., Damiano R.J. Jr. Prevention of myocyte edema with University of Wisconsin Solution a potential mechanism for improved donor heart preservation. Surgical Forum. L:1999;181-182.
49. Chadwick D.R., Robertson G.S.M., Rose S., et al. Storage of porcine pancreatic digest prior to islet purification the benefits of UW Solution and the roles of its individual components. Transplantation. 56:1993;288-293.
50. Menasché P., Hricak B., Pradier F., et al. Efficacy of lactobionate-enriched cardioplegic solution in preserving compliance of cold-stored heart transplants. J Heart Lung Transplant. 12:1993;1053-1061.
51. Burgmann H., Reckendorfer H., Sperlich M., Doleschel W., Spieckermann P.G. The calcium chelating capacity of different protecting solutions. Transplantation. 54:1992;1106-1108.
52. Isaacson Y., Salem O., Shepherd R.E., Van Thiel D.H. Lactobionic acid as an iron chelator a rationale for its effectiveness as an organ preservant. Life Sci. 45:1989;2373-2380.
53. Ko W., Zelano J.A., Lazenby W.D., Isom O.W., Krieger K.H. Compositional analysis of a modified University of Wisconsin solution for extended myocardial preservation a study of the left ventricular pressure-volume relation. J Thorac Cardiovasc Surg. 86:1992;326-332.
54. Baufreton C., Charloux C., Jaffres P., et al. In vivo comparative study of two lactobionate based solutions for prolonged heart preservation. Int J Artif Organs. 18:1995;264-272.
55. Lasley R.D., Mentzer R.M. The role of adenosine in extended mycardial preservation with the University of Wisconsin solution. J Thorac Cardiovasc Surg. 107:1994;356-363.